Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0G1ML
|
|||
| Former ID |
DNC000008
|
|||
| Drug Name |
(35)S-labeled oligonucleotide
|
|||
| Drug Type |
Antisense drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Therapeutic Class |
Antisense
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Protein kinase A alpha messenger RNA (PKA-alpha mRNA) | Target Info | . | [1] |
| Protein kinase A Ri alpha messenger RNA (PKA-Ri-alpha mRNA) | Target Info | . | [1] | |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Antitumor activity and pharmacokinetics of a mixed-backbone antisense oligonucleotide targeted to the RIalpha subunit of protein kinase A after oral administration. Proc Natl Acad Sci U S A. 1999 Nov23;96(24):13989-94. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.